First mRNA Flu Vaccine Receives FDA Approval

Why it matters locally: This FDA approval means that Nebraskans will have access to a new type of flu vaccine developed with mRNA technology for the upcoming flu season, potentially influencing public health strategies across the state.

---

The Food and Drug Administration (FDA) approved an mRNA-based flu vaccine for use in the upcoming flu season. Moderna, the vaccine's developer, created this new immunization technology. This approval represents the first time an mRNA flu vaccine has received authorization from the FDA. The vaccine will become available to the public in time for the next seasonal influenza period.